Remicade (infliximab) - J&J
Stelara (ustekinumab) - J&J
Jyseleca (filgotinib) - Alfasigma, Gilead
Entyvio (vedolizumab) - Takeda
STARTER: FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial (clinicaltrials.gov) - Sep 18, 2026 - P4 | N=240 | Not yet recruiting | Sponsor: University Hospital, Clermont-Ferrand | Initiation date: Jun 2026 ➔ Dec 2026 
Trial initiation date • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
http://clinicaltrials.gov/ct2/show/NCT07576452
 
Sep 18, 2026
 
Prev Next